Myanmar Healthcare Monthly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Myanmar Healthcare Monthly.

Press releases published on September 10, 2026

31 minutes ago

Senseonics To Participate in Upcoming Institutional Investor Conferences

Indeterminate GlobeNewswire

an hour ago

Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy

Indeterminate GlobeNewswire

an hour ago

Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth

Indeterminate GlobeNewswire

an hour ago

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

Indeterminate GlobeNewswire

an hour ago

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Indeterminate GlobeNewswire

an hour ago

Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose

Indeterminate GlobeNewswire

an hour ago

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

Indeterminate GlobeNewswire

an hour ago

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

Indeterminate GlobeNewswire

an hour ago

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

an hour ago

Burning Rock Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment

Indeterminate GlobeNewswire

1 hours ago

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader

Indeterminate GlobeNewswire

2 hours ago

Long-Acting Oligonucleotide Development: Dosing, Yield and Stability Questions

Indeterminate GlobeNewswire

2 hours ago

Actithera significantly strengthens leadership team and Board as Company advances towards clinical development

Indeterminate GlobeNewswire

2 hours ago

Retail Customer Service Outsourcing Now Hinges on Peak-Season Resilience

Indeterminate GlobeNewswire

2 hours ago

Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program

Indeterminate GlobeNewswire

2 hours ago

Shock Top and Auntie Anne’s® Take Over Tailgate Season with the Return of Shock Top Twisted Pretzel Wheat and the Limited-Edition TWIST Vest

Indeterminate GlobeNewswire

2 hours ago

Grey Matters Closes First Tranche of $600,000 of its Equity and Convertible Debenture Private Placement

Indeterminate GlobeNewswire

2 hours ago

Peer-Reviewed Study Published in MDPI’s AI Journal Shows NetraAI Uncovers Clinical Trial Signals Missed by Conventional AI and Foundation Models

Indeterminate GlobeNewswire

2 hours ago

Nkarta to Participate in September Investor Conferences

Indeterminate GlobeNewswire